XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Total
IPO
Total Convertible Preferred Stock
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Series C Convertible Preferred Stock
Preferred Stock
Series A and B Convertible Preferred Stock
Preferred Stock
Total Convertible Preferred Stock
Common Stock
Common Stock
IPO
Common Stock
Series A Convertible Preferred Stock
Common Stock
Series C Convertible Preferred Stock
Common Stock
Series A and B Convertible Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Series C Convertible Preferred Stock
Additional Paid-in Capital
Series A and B Convertible Preferred Stock
Accumulated Deficit
$1.5M Notes
$1.5M Notes
Common Stock
$1.5M Notes
Additional Paid-in Capital
Bridge Notes and Accrued Interest
Bridge Notes and Accrued Interest
Common Stock
Bridge Notes and Accrued Interest
Additional Paid-in Capital
Beginning Balance, Shares at Apr. 30, 2021       10,000 10,000 463,265     3,313,841                              
Beginning Balance at Apr. 30, 2021 $ (1,909,590)     $ 10 $ 10 $ 463   $ 483 $ 3,313         $ 47,661,262       $ (49,574,648)            
Stock based compensation - management & other employees 1,583                         1,583                    
Warrants issued to non-employees 1,609                         1,609                    
Net loss (501,851)                                              
Ending Balance, Shares at Jul. 31, 2021       10,000 10,000 463,265     3,313,841                              
Ending Balance at Jul. 31, 2021 (1,906,398)     $ 10 $ 10 $ 463   483 $ 3,313         47,664,454       (49,574,648)            
Beginning Balance, Shares at Apr. 30, 2021       10,000 10,000 463,265     3,313,841                              
Beginning Balance at Apr. 30, 2021 (1,909,590)     $ 10 $ 10 $ 463   483 $ 3,313         47,661,262       (49,574,648)            
Sale of common stock and warrants, net of fees, Shares     0                                          
Ending Balance, Shares at Apr. 30, 2022       10,000 10,000 463,265     3,323,942                              
Ending Balance at Apr. 30, 2022 $ (6,055,797)     $ 10 $ 10 $ 463   483 $ 3,323         48,343,305       (54,402,908)            
Sale of common stock and warrants, net of fees, Shares 4,850,433   0           4,850,433 1,500,000                            
Sale of common stock and warrants, net of fees   $ 5,194,740               $ 1,500         $ 5,193,240                  
Common stock issued upon conversion, Shares       (10,000) (10,000) (50,676)         703,290 193,958 703,290             909,071     1,544,114  
Common stock issued upon conversion of convertible preferred stock       $ (10) $ (10) $ (50) $ (20)         $ 194 $ 703     $ (144) $ (683)   $ 1,500,000 $ 909 $ 1,499,091 $ 3,618,704 $ 1,544 $ 3,617,160
Stock based compensation - management & other employees $ 145,722                         145,722                    
Warrants issued to non-employees 57,203                         57,203                    
Net loss (1,573,303)                                 (1,573,303)            
Ending Balance, Shares at Jul. 31, 2022           412,589     8,174,375                              
Ending Balance at Jul. 31, 2022 $ 2,887,269         $ 413   $ 413 $ 8,173         $ 58,854,894       $ (55,976,211)